相关实验视频

Updated: Jun 18, 2026

Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology
11:20

Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology

Published on: March 21, 2018

10.8K

在甲状腺癌中测试TP53突变的理由-原始数据和元分析

Katarzyna Lacka1, Adam Maciejewski1, Piotr Tyburski2

  • 1Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 60-355 Poznan, Poland.

International journal of molecular sciences
|February 13, 2025
PubMed
概括

TP53突变在厌塑性甲状腺癌 (ATC) 中很常见,但在差异化甲状腺癌 (DTC) 中很少见. p53过度表达是DTC和ATC的标志物,需要进一步研究DTC的预后价值.

关键词:
免疫组织化学 免疫组织化学这是一个元分析.突变是一种突变.在 p53 里,p53 是一个 p53 号码.甲状腺癌是一种癌症.

更多相关视频

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

9.5K
Spontaneous Murine Model of Anaplastic Thyroid Cancer05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

1.6K

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...